742 combined drugs to be in non-NHI reimbursement scheme.

Published: 2006-11-03 06:59:00

Updated: 2006-11-03 06:59:00

As planned 742 combined drugs are excluded from the NHI reimbursement schedule taking effects from Nov. 1., under which many of them seem to be returned in fear of idle stocks at the pharmacy shelf.

The Drug Review Commission determined that 742 non-prescription combined drugs should be delet...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK